Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
Dose: Cattle (meat and milk) and Pigs: 5 ml
Looking for Safe and Effective Compounded Medications in the DMV Area
TB-500 and Thymosin Beta-4 are also prohibited by WADA/USADA under S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics), applicable at all times both in-competition and out-of-competition TB-500 / Thymosin Beta-4 Clinical Trials: The RGN-352 and RGN-259 Programs RegeneRx Biopharmaceuticals has pursued two clinical development programs for Thymosin Beta-4, providing the most substantial human clinical data available for any TB-500-related compound: RGN-352 (Injectable Thymosin Beta-4 for Cardiac Repair): Phase 1 trial (completed): A double-blind, placebo-controlled study enrolled 40 healthy volunteers across four cohorts of 10 subjects each, testing escalating dose levels of intravenous Thymosin Beta-4 administered daily over 14 days
View Deal Best COA Transparency Infiniwell BPC RAPID PRO Industry-leading quality assurance and rigorous third-party lab verification for absolute trust
Up to 80% of circulating B12 is in the inactive form
US$ 24.35
US$ 22.13
US$ 20.66
US$ 23.82
US$ 27.73
